WHO ICTRP trial
A multi-center, prospective, real-world study of Linaclotide in the treatment of…
ChiCTR2100052551 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100052551 |
|---|---|
| Public title | A multi-center, prospective, real-world study of Linaclotide in the treatment of irritable bowel syndrome with predominant constipation |
| Scientific title | A multi-center, prospective, real-world study of Linaclotide in the treatment of irritable bowel syndrome with predominant constipation |
| Primary sponsor | The Second Hospital of Shandong University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 4 |
| Countries | China |
| Conditions | Irritable Bowel Syndrome |
| Interventions | case group:Nil |
| Registration date | Oct 31, 2021 |
| Target size | case group:120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: